Blood Glucose Meters Industry Data Book - Point-of-care Glucose Testing Devices, Self-Monitoring Continuous Blood Glucose Monitors Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030

The global blood glucose monitoring devices market generated over USD 12.53 billion revenue in 2022 and is projected to expand at a CAGR of around 8.1% during the forecast period to reach USD 23.15 billion by 2030.

Blood Glucose Meters Industry Data Book Coverage –

Blood Glucose Meters Industry Data Book Coverage Snapshot

Access the Global Blood Glucose Meters Industry Data Book, 2023 to 2030, compiled with details like market sizing information forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory technological framework studies

Point-of-Care Glucose Testing Market Growth Trends

The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period, according to a new report by Grand View Research, Inc. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Various companies are investing in the development of needle-less devices to offer painless management of diabetes. For instance, GlucoTrack, a product manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real-time. The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals, such as silver, gold, and platinum, which effectively reduce the electrical noise further improving accuracy.

Continuous Glucose Monitoring Devices Market Growth Trends

The global continuous glucose monitoring devices market size is expected to reach USD 11.2 billion by 2030, registering a CAGR of 4.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The two primary factors propelling the market expansion are the rise in diabetes incidences and the launch of technologically advanced diabetes care devices. Continuous glucose monitoring (CGM) devices are effective to evaluate body glucose levels in real-time. These devices transmit the data they collect across a wireless network to receivers, which aids in tracking the levels of glucose during a certain time.

While lowering individual insulin dosages, these devices also assist in managing diabetes. These devices' built-in software gives users access to information on food consumption, medicine use, physical activity, and illnesses. As a result, a growing number of diabetic patients are employing these devices to control and treat their condition, which is fueling market expansion.

A growing number of continuous glucose monitoring devices are being integrated with apps and software to assist patients with diabetes mellitus as a result of the development of digital treatments. Apps such as Glucose buddy, Diabetes Connect, My Sugar, and others are available under a paid subscription.

Furthermore, the rise in the number of diabetes mellitus has contributed significantly toward the CGM systems market growth. The device allows real-time biofeedback and behavioral change support, allowing effective management of diabetes by the patient. Additionally, the government is spending a huge amount on diabetic care tools to closely monitor diabetes in patients.

Order your copy of the Free Sample of “Blood Glucose Meters Industry Data Book - Point-of-care Glucose Testing Devices, Self-Monitoring Continuous Blood Glucose Monitors Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

Competitive Landscape

Key players operating in the blood glucose meters industry are –

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care
• Lifescan Inc
• Dexcom, Inc
• Sanofi
• Elly Lilly and Company
• B Braun Melsungen AG
• Nipro
• Nova Biomedical
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• EKF Diagnostics

Grand View Research’s blood glucose meters Industry data book is a collection of market sizing information forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/sector-reports-list

Follow Us: LinkedIn | Twitter